BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8363999)

  • 1. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience.
    Sorbe B
    Ann Oncol; 1993; 4 Suppl 3():39-42. PubMed ID: 8363999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting--the Nordic experience.
    Sorbe B; Andersson H; Schmidt M; Söderberg M; Högberg T; Wernstedt L; Janson ET; Ehrnström B; Kjaer M; Havsteen H
    Support Care Cancer; 1994 Nov; 2(6):393-9. PubMed ID: 7858934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy.
    Bleiberg H; Hulstaert F; Buyse M; De Keyser P
    Anticancer Drugs; 1998 Oct; 9(9):773-7. PubMed ID: 9840722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy.
    Bruntsch U; Rüfenacht E; Parker I; Drechsler S; de Bruijn K
    Ann Oncol; 1993; 4 Suppl 3():25-9. PubMed ID: 8363995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
    Simpson K; Spencer CM; McClellan KJ
    Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy.
    Sorbe B; Högberg T; Himmelmann A; Schmidt M; Räisänen I; Stockmeyer M; de Bruijn KM
    Eur J Cancer; 1994; 30A(5):629-34. PubMed ID: 8080678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
    Gershanovich M; Kolygin B; Pirgach N
    Ann Oncol; 1993; 4 Suppl 3():35-7. PubMed ID: 8363998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin.
    Schmidt M; Sorbe B; Högberg T; Himmelmann A; Räisänen I; Stockmeyer M; de Bruijn KM
    Ann Oncol; 1993; 4 Suppl 3():31-4. PubMed ID: 8363997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
    Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
    Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I; Moid I; Khan Z; Hussain M
    Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe B; Hallén C; Frankendal B
    Cancer Chemother Pharmacol; 1994; 33(4):298-302. PubMed ID: 8281622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues in the management of nausea and vomiting.
    Gralla RJ
    Ann Oncol; 1993; 4 Suppl 3():3-7. PubMed ID: 8363996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
    Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
    Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open multicentre study of tropisetron for cisplatin-induced nausea and vomiting.
    Olver IN; Craft PS; Clingan PR; Kearsley JH; Planner RS; van Hazel GA; Bell DR; Adena MR; Hall BE; Pearson LL
    Med J Aust; 1996 Mar; 164(6):337-40. PubMed ID: 8606657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.